The Journal of Population Therapeutics and Clinical Pharmacology: A Peer-Reviewed Resource in Medical Research The Journal of Population Therapeutics and Clinical Pharmacology (JPTCP) is an international, peer-reviewed publication dedicated to advancing knowledge in clinical pharmacology and therapeutics. The journal welcomes original research, review articles, and case reports covering a broad spectrum of medical and pharmacological practice. It serves researchers, clinicians, and academics seeking evidence-based insights into drug therapy, treatment outcomes, and population health. Published by Mikky Publication Services PVT. LTD., JPTCP maintains a commitment to scientific rigor and accessibility. The journal operates on a bi-annual publication schedule and provides content in English. Articles are made available through open access, supporting wider dissemination of findings within the global medical community. JPTCP is indexed in major academic databases, including Scopus, PubMed, the ISSN Portal, and the National Library of Medicine (NLM). These inclusions reflect its recognition as a credible source of scholarly operate in the fields of health policy, medicine, and pharmacology. The journal’s content spans numerous specialties, from cardiology and oncology to infectious diseases and reproductive medicine, underscoring its interdisciplinary scope. According to verified metrics, the Journal of Population Therapeutics and Clinical Pharmacology holds an impact score of 1.94, as reported in 2025. This figure represents the average number of citations received by articles published in the journal over the preceding two years. The journal’s SCImago Journal Rank (SJR) is 0.277, and it holds an h-index of 43, indicating sustained academic influence and productivity. JPTCP is classified within the third quartile (Q3) for its subject categories, reflecting its standing among peer publications in health policy, miscellaneous medicine, and medical pharmacology. The journal’s editorial scope explicitly includes submissions on clinical and epidemiological studies, therapeutic innovations, and pharmacological interventions. Recent issues have featured research on topics such as postoperative sore throat prevention, head and neck squamous cell carcinoma, laryngeal papillomatosis, lumbar spinal stenosis, antihypertensive drug reactions, and metabolic comparisons between diabetic and non-diabetic populations. Authors interested in contributing to JPTCP can submit manuscripts through the journal’s official channels. The publication adheres to standard peer-review processes to ensure the quality and validity of all accepted work. While an article processing charge (APC) applies for open access publishing, the journal remains committed to transparent and ethical scholarly communication. As a trusted platform for pharmacological and clinical research, the Journal of Population Therapeutics and Clinical Pharmacology continues to support the global exchange of medical knowledge. Its focus on population-level therapeutics and real-world clinical applications positions it as a valuable resource for improving patient care and informing public health strategies.
12